Intervention for alcohol use disorders at an HIV care clinic in Harare: a pilot and feasibility study.
Adult
Alcohol-Related Disorders
/ epidemiology
Ambulatory Care Facilities
/ organization & administration
Antiretroviral Therapy, Highly Active
/ methods
CD4 Lymphocyte Count
Cognitive Behavioral Therapy
/ methods
Feasibility Studies
Female
HIV Infections
/ drug therapy
Humans
Male
Medication Adherence
Middle Aged
Motivational Interviewing
/ methods
Nurses
/ organization & administration
Pilot Projects
Psychotherapy
/ methods
Psychotherapy, Brief
Quality of Life
Sexual Behavior
Socioeconomic Factors
Viral Load
Zimbabwe
Alcohol
HIV
MI/CBT intervention
Psychological
Task sharing
Zimbabwe
Journal
Addiction science & clinical practice
ISSN: 1940-0640
Titre abrégé: Addict Sci Clin Pract
Pays: England
ID NLM: 101316917
Informations de publication
Date de publication:
05 04 2019
05 04 2019
Historique:
received:
01
06
2018
accepted:
14
03
2019
entrez:
7
4
2019
pubmed:
7
4
2019
medline:
19
5
2020
Statut:
epublish
Résumé
Alcohol use in HIV infected patients is associated with risky sexual behaviour, poor adherence to Highly Active Antiretroviral Therapy, treatment failure and increased physiologic harm. The objectives of the study were to pilot the outcome assessments to be used in the trial proper, assess the feasibility of delivery of a brief MI/CBT intervention compared to an WHO mhGAP intervention for problematic alcohol use in PLWH in Zimbabwe, and pilot the effectiveness (on alcohol use, functionality and CD4 count) of these interventions at 3 months in a randomised controlled trial design. An intervention for HIV infected patients with problematic alcohol use, developed through adaptation of existing evidence based psychological treatments, was assessed for its feasibility at a tertiary HIV care clinic in Zimbabwe. Registered general nurses, using a manualised protocol, delivered the intervention. Forty patients were recruited and randomised to receive either an MI/CBT intervention or the WHO mhGAP Intervention Guide for AUDs (n = 20 patients per group). Out of 40 participants enrolled, 31 were successfully followed up for 3 months with a loss to follow-up rate of 23%. There was a statistically significant decrease in AUDIT score over time in both groups (p < 0.001), however no statistically significant group difference with a mean difference of 0.80, standard error of 2.07 and p = 0.70. For the CD4 count, the median and interquartile ranges at baseline for MI/CBT and WHO mhGAP IG groups were 218 (274) and 484 (211.50), respectively. At follow-up, median and interquartile ranges for the CD4 count for MI/CBT and WHO mhGAP IG groups were 390 (280) and 567 (378), respectively, indicative of improvement in immunological parameters in both arms. The findings from this pilot study suggests that a brief MI/CBT delivered by Registered General Nurses for problematic alcohol use is feasible in this population but will require the implementation of additional measures to improve retention. However, mechanisms to improve retention need special attention. Trial registration Pan African Clinical Trial Registry, current PACTR201509001211149.
Sections du résumé
BACKGROUND
Alcohol use in HIV infected patients is associated with risky sexual behaviour, poor adherence to Highly Active Antiretroviral Therapy, treatment failure and increased physiologic harm. The objectives of the study were to pilot the outcome assessments to be used in the trial proper, assess the feasibility of delivery of a brief MI/CBT intervention compared to an WHO mhGAP intervention for problematic alcohol use in PLWH in Zimbabwe, and pilot the effectiveness (on alcohol use, functionality and CD4 count) of these interventions at 3 months in a randomised controlled trial design.
METHODS
An intervention for HIV infected patients with problematic alcohol use, developed through adaptation of existing evidence based psychological treatments, was assessed for its feasibility at a tertiary HIV care clinic in Zimbabwe. Registered general nurses, using a manualised protocol, delivered the intervention. Forty patients were recruited and randomised to receive either an MI/CBT intervention or the WHO mhGAP Intervention Guide for AUDs (n = 20 patients per group).
RESULTS
Out of 40 participants enrolled, 31 were successfully followed up for 3 months with a loss to follow-up rate of 23%. There was a statistically significant decrease in AUDIT score over time in both groups (p < 0.001), however no statistically significant group difference with a mean difference of 0.80, standard error of 2.07 and p = 0.70. For the CD4 count, the median and interquartile ranges at baseline for MI/CBT and WHO mhGAP IG groups were 218 (274) and 484 (211.50), respectively. At follow-up, median and interquartile ranges for the CD4 count for MI/CBT and WHO mhGAP IG groups were 390 (280) and 567 (378), respectively, indicative of improvement in immunological parameters in both arms.
CONCLUSION
The findings from this pilot study suggests that a brief MI/CBT delivered by Registered General Nurses for problematic alcohol use is feasible in this population but will require the implementation of additional measures to improve retention. However, mechanisms to improve retention need special attention. Trial registration Pan African Clinical Trial Registry, current PACTR201509001211149.
Identifiants
pubmed: 30953549
doi: 10.1186/s13722-019-0143-7
pii: 10.1186/s13722-019-0143-7
pmc: PMC6451208
doi:
Banques de données
PACTR
['PACTR201509001211149']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
16Références
Lancet. 2007 Sep 15;370(9591):991-1005
pubmed: 17804058
Semin Liver Dis. 2012 May;32(2):103-13
pubmed: 22760649
J Stud Alcohol. 1995 Jul;56(4):423-32
pubmed: 7674678
BMC Psychiatry. 2017 Jan 28;17(1):44
pubmed: 28129756
Addiction. 2014 Mar;109(3):394-406
pubmed: 24304463
AIDS Care. 2011 Aug;23(8):1035-42
pubmed: 21500023
Addict Sci Clin Pract. 2016 Jan 13;11(1):1
pubmed: 26763048
Cent Afr J Med. 1999 Nov;45(11):303-8
pubmed: 10892457
Subst Abus. 2007;28(4):79-92
pubmed: 18077305
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Br J Addict. 1986 Feb;81(1):23-46
pubmed: 3457598
Alcohol Res Health. 2010;33(3):280-7
pubmed: 23584069
Alcohol Clin Exp Res. 2008 Sep;32(9):1645-51
pubmed: 18616666
Curr HIV/AIDS Rep. 2013 Dec;10(4):356-70
pubmed: 23990322
PLoS One. 2017 Jun 30;12(6):e0180015
pubmed: 28665974
PLoS Med. 2017 Sep 12;14(9):e1002386
pubmed: 28898239
J Stud Alcohol. 1998 Nov;59(6):631-9
pubmed: 9811084
Drug Alcohol Depend. 2016 Apr 1;161:95-103
pubmed: 26861883
Nature. 2015 Nov 19;527(7578):S172-7
pubmed: 26580324
BMJ Glob Health. 2016 Dec 30;1(4):e000125
pubmed: 28588979
J Stud Alcohol. 1998 Jan;59(1):124-5
pubmed: 9498325
Antivir Ther. 2005;10(1):83-93
pubmed: 15751766
Fam Process. 2006 Jun;45(2):143-51
pubmed: 16768015
Addiction. 2011 Dec;106(12):2156-66
pubmed: 21631622
Lancet. 2017 Jan 14;389(10065):186-195
pubmed: 27988144
J Assoc Nurses AIDS Care. 2011 Jan-Feb;22(1):53-66
pubmed: 20619690
BMC Infect Dis. 2017 Apr 11;17(1):263
pubmed: 28399823
Patient Prefer Adherence. 2014 Mar 31;8:401-13
pubmed: 24729688
Lancet. 2012 Sep 8;380(9845):889-98
pubmed: 22901955
AIDS Care. 2014;26(12):1494-9
pubmed: 25040338
J Stud Alcohol. 2002 Mar;63(2):179-86
pubmed: 12033694
Med Clin (Barc). 2005 Nov 26;125(19):727-30
pubmed: 16324465
Drug Alcohol Depend. 2010 Dec 1;112(3):178-93
pubmed: 20705402
AIDS Res Hum Retroviruses. 2013 May;29(5):799-804
pubmed: 23294471
HIV AIDS (Auckl). 2016 Apr 26;8:83-92
pubmed: 27175095
Addiction. 2002 Mar;97(3):279-92
pubmed: 11964101
Trials. 2014 Nov 21;15:457
pubmed: 25416557
Glob Health Action. 2015 Mar 16;8:26682
pubmed: 25783229
BMC Public Health. 2017 Jun 2;17(1):542
pubmed: 28577548
Health Qual Life Outcomes. 2010 May 19;8:51
pubmed: 20482853
Curr Opin Psychiatry. 2008 May;21(3):229-33
pubmed: 18382219
AIDS Care. 2004 Oct;16(7):882-9
pubmed: 15385243
Eur Addict Res. 2005;11(1):22-31
pubmed: 15608468
J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):443-50
pubmed: 18077833
AIDS Patient Care STDS. 2005 Feb;19(2):89-99
pubmed: 15716640
Cent Afr J Med. 1993 Feb;39(2):26-32
pubmed: 8261500
BMC Infect Dis. 2014 Sep 12;14:500
pubmed: 25212696
BMC Res Notes. 2014 Nov 24;7:828
pubmed: 25417542
Addict Behav. 2010 Apr;35(4):302-11
pubmed: 19932936
Glob Health Action. 2015 Oct 06;8:28209
pubmed: 26446286
AIDS Behav. 2016 Mar;20(3):504-11
pubmed: 26936030
Contemp Clin Trials. 2017 Sep;60:125
pubmed: 28712767
Health Qual Life Outcomes. 2017 Apr 5;15(1):64
pubmed: 28381230